EZETIMIB ROSUVAST Zentiva cpr pell 10/20 mg 30 pce

7680685260031 CH-68526 C10BA06 07.12.0.

Reimbursement limitations:

EZETROSZENTI

EZETIMIB ROSUVASTATIN ZENTIVA est indiqué comme traitement substitutif chez le patient adulte qui reçoit déjà …

EZETIMIB ROSUVAST Zentiva cpr pell 10/20 mg 30 pce
EZETIMIB ROSUVAST Zentiva cpr pell 10/20 mg 30 pce
EZETIMIB ROSUVAST Zentiva cpr pell 10/20 mg 30 pce
1 / 3
google

Details

Product number
6852602
CPT
-
Packaging group
30
Unit
Tablette(n)
Composition
ezetimibum 10 mg, rosuvastatinum 20 mg ut rosuvastatinum calcicum 20.8 mg, lactosum monohydricum 200.5 mg, carmellosum natricum conexum, povidonum K 30, natrii laurilsulfas, cellulosum microcristallinum, hypromellosum, silica colloidalis anhydrica, magnesii stearas, Überzug: hypromellosum, E 171, talcum, macrogolum 4000, E 172 (flavum), pro compresso obducto corresp. natrium 3 mg.

Articles (1)

Ezetimib Rosuvastatin Zentiva 10 mg / 20 mg, Filmtabletten
Filmtabletten
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/03/2025
Patient information leaflet
Français
22/03/2025
Patient information leaflet
Italien
22/03/2025
Professional SmPC
Allemand
22/03/2025
Professional SmPC
Français
22/03/2025
Professional SmPC
Italien
22/03/2025

Detailed composition

Substance Quantity Type Category
(N/A)
10.0 MG Substance Wirkstoff (Principe actif)
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
20.8 MG Substance WIZUS
(N/A)
200.5 MG Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
3.0 MG Substance HBESI

Reimbursement information

Public price
CHF 39.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/06/2023

Authorization holder

Helvepharm AG

8500 Frauenfeld

Authorization information

Swissmedic authorization number
68526
Drug name
Ezetimib Rosuvastatin Zentiva, Filmtabletten
Galenic form
FILM
ATC Code
C10BA06
Authorization status
Z
Dispensation category
B
First authorization
29/09/2022
Authorization expiration date
28/09/2027
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration

Packaging details

Description (FR)
EZETIMIB ROSUVAST Zentiva cpr pell 10/20 mg 30 pce
Description (DE)
EZETIMIB ROSUVAST Zentiva Filmtabl 10/20 mg 30 Stk
Market launch
29/09/2022
Narcotic (BTM)
No

Other packaging sizes

EZETIMIB ROSUVAST Zentiva cpr pell 10/10 mg 30 pce
30 TABL
View
EZETIMIB ROSUVAST Zentiva cpr pell 10/10 mg 90 pce
90 TABL
View
EZETIMIB ROSUVAST Zentiva cpr pell 10/20 mg 90 pce
90 TABL
View